Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Impax Laboratories
Pharma
California bans pharma's infamous 'pay-for-delay' deals
In an effort to keep drug prices down, California is looking to end a longtime pharma practice that keeps generic challengers off the market.
Kyle Blankenship
Oct 8, 2019 10:45am
Amneal chairman Paul Bisaro, CEO exit in leadership shakeup
Aug 5, 2019 12:00pm
Feds: Impax struck 'pay-for-delay' deal with Endo on Opana ER
Apr 1, 2019 9:47am
Allergan architect Bisaro exits board as revamp continues
Aug 30, 2018 11:11am
Teva copycat of Mylan's EpiPen wins FDA nod after 2-year delay
Aug 16, 2018 5:20pm
Kaléo boasts it has an available supply of epinephrine injectors
Aug 15, 2018 11:33am
